Systematic review of unveiling the potential of AI using machine learning and deep learning methods in neurodegenerative diseases.

Overview

1. School of Computer Science Engineering and Information Systems, Vellore Institute of Technology, Vellore, Tamil Nadu, India

Abstract

Background: Neurodegenerative diseases (NDDs) are becoming a major worldwide issue, especially for the elderly because they are incurable and permanent. It is extremely difficult to provide any medication to people suffering from NDDs. Comprehending essential processes of NDDs are essential to establishing alternative strategies that can increase survival rates in patients. This review is an effort to provide insight into NDDs, innovative therapeutic methods along with their clinical significances and thus provide opportunities for improving therapies for NDDs in the near future.

Objective: This work aims at a thorough, methodical and critical evaluation of Machine Learning (ML)/Deep Learning (DL) efforts in diagnostics of NDDs, as well as their potential for use in pharmacological, clinical and research settings. An additional objective is to discuss problems and limitations of models, with an eye on furthering research directions.

Methods: The databases of Elsevier, Sage, Wiley, Springer Link, Emerald Insights and Research Gate were searched for useful assessments of NDDs using ML/DL approaches.

Results: Numerous potential diagnostic ML/DL models have been suggested and effectively applied to detect NDDs. Biological, neuroimaging and key clinical characteristics in patients have been used to evaluate prognostic models. Additionally, these models provide options for patient categorization, facilitate earlier detections, enhanced diagnosis and better disease outcome predictions for personalized therapies.

Conclusion: This work points out the rising burden of NDDs on the global elderly while highlighting the significances of ML/DL technological advancements with their limitations for NDDs in diagnostics, identification of effective disease bio-markers and management.

Reproduced under the paper's license (CC BY), from the paper cited above.

Code

The paper links to its data, not to its authors' code: see the Data section.

The paper's code and data availability statement is in the Data section.

Tracing map

A tracing map links a paper to the code its authors published: this paper has none, so it has no map.

Data

Datasets cited

• geo:GSE63060 — at NCBI GEO; found in the resources table

Data Availability

The following information was supplied regarding data availability:

Gitup Link: https://github.com/SMohanraj4036/Systematic-Review-of-Neurodegenerative-Diseases

Zenodo Link: DOI 10.5281/zenodo.18898570 (https://doi.org/10.5281/zenodo.18898570)

This manuscript is a systematic literature review. All data discussed in this article are obtained from previously published studies and are available from the corresponding references cited within the manuscript.

Reproduced under the paper's license (CC BY), from the paper cited above.

Versions

The history of this record: each version stored by the harvester or made by a correction of its authors or of the maintainers of its code, and what changed in its facts. The texts of the paper (its abstract, its availability statements) are not part of it; versions that changed only those are not listed.

Version 1, 27 September 2026: the first record

Recorded: type, language, journal, volume, pages, dates, 2 authors, 5 keywords, 71 references.

Cite

This paper

Mohanraj, S., & Radhakrishnan, S. (2026). Systematic review of unveiling the potential of AI using machine learning and deep learning methods in neurodegenerative diseases. PeerJ. Computer science, 12, e3860. https://doi.org/10.7717/peerj-cs.3860

Similar papers

The papers with a page that share the most with this one: the tools found in their code, their categories, datasets, cited references and authors, the rarest counting most.

[1] doi:10.3390/bioengineering13080917 [code]

Pilot Study Employing a Machine Learning Approach as a Potential Method for Predicting Parkinson's Disease Using Voice as a Digital Biomarker and the SHAP Approach for Feature Engineering.

Journal: Bioengineering (Basel, Switzerland)

In common: Parkinson's, 2 references

[2] doi:10.1186/s12951-026-04551-7

The role of AI-assisted drug repurposing in neurological disorders: a systematic review of validation strategies, challenges and opportunities.

Journal: Journal of nanobiotechnology

In common: Parkinson's, Alzheimer's / dementia, other condition, 1 reference

[3] doi:10.1016/j.nbd.2026.107379 [code]

DYRK1A and Parkinson's disease, facts and hypotheses.

Journal: Neurobiology of disease

In common: Parkinson's, Alzheimer's / dementia, 1 reference

[4] doi:10.3390/antiox15080926

NRF2 Deletion Results in Mobility Impairment in A53TSyn Model of Synucleinopathy.

Journal: Antioxidants (Basel, Switzerland)

In common: Parkinson's, 1 reference

[5] doi:10.1002/ana.78252 [code]

Diffusion MRI and α-Synuclein Seed Amplification Status in Parkinson's Disease.

Journal: Annals of neurology

In common: Parkinson's, 1 reference

[6] doi:10.1007/s11571-026-10526-z

A task-aligned multimodal machine learning framework for studying working memory dysfunction in Parkinson's disease.

Journal: Cognitive neurodynamics

In common: Parkinson's, 1 reference

[7] doi:10.3390/brainsci16080781 [code]

A Comparison of Machine Learning Models for Classification of Parkinson's Disease During a Working Memory and Sustained Attention Task.

Journal: Brain sciences

In common: Parkinson's, 1 reference

[8] doi:10.1038/s41598-026-50523-0 [code]

Mechanistic multiscale modeling identifies putative natural tri-target candidates of MAO-B, LRRK2 and A₂A for Parkinson's disease.

Journal: Scientific reports

In common: Parkinson's, 1 reference

[9] doi:10.1093/brain/awag043

Cytomegalovirus-induced T cell responses accelerate Alzheimer's disease progression in mice.

Journal: Brain : a journal of neurology

In common: Alzheimer's / dementia, other condition, 1 reference

[10] doi:10.1038/s41467-026-74817-z [code]

Early-Stage Corticostriatal Hyperactivity Impairs Cognitive Flexibility Alongside Striatal Cholinergic Dysfunction in an Alzheimer's Disease Model.

Journal: Nature communications

In common: Alzheimer's / dementia, 1 reference

Contribute

The authors of this paper can claim it, correct its record and validate its tracing map, and the maintainers of its code (its owner, or a public member of its organization) correct what it says of their repository; anyone signed in can ask for its removal. Every request goes to OSCR's own machine, which answers it; your account page follows them.

Request its removal

To ask OSCR to remove this record, the copies of its authors' scripts or its tracing map, use the removal request page: signed in, you say who you are, what to remove and why, then review and confirm the request. Published rules decide every request (how).

Discussion: questions and error reports about this paper and its code, from signed-in readers and its authors. It opens with sign-in.

Reproductions: reports from readers who ran the authors' code: what they reproduced, with which environment, commit and data. It opens with sign-in.

Activity: what happens around this paper: new versions of its record, its map's validation, discussions and reproductions. It opens with sign-in.